Cognition Therapeutics Inc

CGTX

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001455365

SEC filings (opens in a new tab)

No open-market purchases or sales by Cognition Therapeutics Inc insiders were filed in the last 90 days; 66 institutions reported holding it in 13F filings for Q2 2026, worth $26.0M in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Cognition Therapeutics Inc changed between Q2 2023 and Q3 2023.

All holders in Q3 2023 All holders in Q2 2023

13F holders of CGTX: Q2 2023 compared with Q3 2023
Measure	Q2 2023	Q3 2023	Change
Holders	35	36	+1
Shares	7.10M	7.24M	+135.3K (+1.9%)
Value	$13.0M	$10.4M	−$2.57M (−19.8%)

New holders (2)

Institutions that held Cognition Therapeutics Inc at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to CGTX in Q3 2023
Institution	Shares	Value	% of portfolio
Steward Financial Group LLC	40,874	$58.0K	0.02%
Bank of America Corp	5,000	$7.20K	0.00%

Sold out (1)

Institutions that held Cognition Therapeutics Inc at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of CGTX in Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
UBS Group AG	610	$1.12K